Showing results (101-110 of 609) with videos related to

Sort By:
Pageof 61
BJU International|September 25, 2012
Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) RotterdamStacy Loeb, Xiaoye Zhu, Fritz H Schroder, et al.
Prostate Cancer and Prostatic Diseases|July 25, 2023
Prostate cancer and podcasts: an analysis and assessment of the quality of information about prostate cancer available on podcastsColin Scott, Peter Campbell, Amy Nemirovsky, et al.
The Journal of Urology|September 6, 2006
Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortalityStephen J Freedland, Elizabeth B Humphreys, Leslie A Mangold, et al.
The Journal of Urology|March 20, 2012
Radical prostatectomy outcome in men 65 years old or older with low risk prostate cancerJeffrey K Mullins, Misop Han, Phillip M Pierorazio, et al.
Human Pathology|August 31, 2002
Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy?Michael P Viglione, Stephen Potter, Alan W Partin, et al.
BJU International|April 8, 2018
Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefitMohit Gupta, Hiten D Patel, Zeyad R Schwen, et al.
The Prostate|July 13, 2010
Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomyRobert W Veltri, Sumit Isharwal, M Craig Miller, et al.
Urology|July 3, 2003
Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003Masood A Khan, Misop Han, Alan W Partin, et al.
BJU International|June 26, 2004
Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSAJ Kellogg Parsons, Michael K Brawer, Carol D Cheli, et al.
BJU International|May 6, 2019
Genomic classifiers for treatment selection in newly diagnosed prostate cancerNoam David Fine, Fred LaPolla, Matthew Epstein, et al.
Pageof 61